|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Net income (loss) | |||||
| Net loss | |||||
| Adjustments to reconcile net (loss) income to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Impairment of goodwill and intangible assets | |||||
| Loss on assets held for sale | |||||
| Property, plant and equipment and other asset write-offs | |||||
| Inventory write-downs | |||||
| Other non-cash charges related to restructuring and transformation | |||||
| Stock-based compensation | |||||
| Contingent consideration adjustment | |||||
| Amortization and accretion on marketable securities | |||||
| Deferred income taxes | |||||
| Loss on extinguishment of debt | |||||
| Purchase accounting impact on inventory | |||||
| Loss on disposals of property, plant and equipment | |||||
| Gain on divestiture, net of tax | |||||
| Fees paid stemming from divestiture | |||||
| Taxes paid stemming from divestiture | |||||
| Changes in operating assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Other current assets and liabilities | |||||
| Accrued warranty and retrofit costs | |||||
| Accrued compensation and tax withholdings | |||||
| Long term income taxes receivable | |||||
| Other assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Cash flows from investing activities | |||||
| Purchases of property, plant and equipment | |||||
| Purchases of technology intangibles | |||||
| Purchases of marketable securities and other investments | |||||
| Sales and maturities of marketable securities | |||||
| Proceeds from divestiture, net of cash transferred | |||||
| Proceeds from other investment | |||||
| Net investment hedge settlement | |||||
| Acquisitions, net of cash acquired | |||||
| Net cash (used in) provided by investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from issuance of common stock | |||||
| Principal payments on debt | |||||
| Payments of finance leases | |||||
| Payment for contingent consideration related to acquisition | |||||
| Withholding tax payments on net share settlements on equity awards | |||||
| Share repurchases | |||||
| Common stock dividends | |||||
| Excise tax payment for settled share repurchases | |||||
| Net cash used in financing activities | |||||
| Effects of exchange rate changes on cash, cash equivalents and restricted cash | |||||
| Net decrease in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash, beginning of period | |||||
| Cash, cash equivalents and restricted cash, end of period | |||||
| Supplemental disclosures: | |||||
| Cash paid for interest | |||||
| Cash paid for income taxes, net | |||||
| Purchases of property, plant and equipment included in accounts payable and accrued expenses | |||||
| Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets | |||||
| Cash and cash equivalents of continuing operations | |||||
| Cash included in current assets held for sale | |||||
| Short-term restricted cash included in prepaid expenses and other current assets | |||||
| Long-term restricted cash included in other assets | |||||
Loading...